Endocrine Disruption in Practice: From EAS-Modalities to Weight-of-Evidence Strategies 🔬

Following the success of our webinar last year on the T-modality, we are excited to invite you to the next edition of our regulatory series on Endocrine Disruptors!

While thyroid signaling presents its own unique data requirements and testing challenges, navigating Estrogen, Androgen, and Steroidogenesis (EAS) modalities brings a whole new set of considerations under the EFSA/ECHA ED Guidance for both PPP and BPR frameworks.

Join our expert team as we go beyond the basics to explore:

🔹 Key screening endpoints & mechanistically-linked OECD test guidelines for EAS modalities

🔹 Weight-of-Evidence (WoE) strategies for resolving equivocal data and lines of evidence

🔹 Practical lessons learned from recent Member State authority reviews and confirmatory data requests

📅 Date: 24 of November 2026

⏰ Time: 3 pm CET time

📍 Location: Live Online

Whether you are working on dossiers, managing regulatory testing strategies, or preparing responses to authority queries, this session will offer concrete, actionable insights.

👉 Register here

Webinar ED by Staphyt

Share this post: